6 terminated. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
| Phase 2 | 3 | Terminated 3 |
Follow Polymyositis: new trials by email Literature Review of Polymyositis trials Research Report on Polymyositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis Ravulizumab, Placebo - Dermatomyositis | Phase 2 / Phase 3 | Terminated | Alexion Pharmaceuticals, Inc. | 38 | 2021-11-19 | 2025-07-09 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) human immunoglobulin G, Placebo - Dermatomyositis | Phase 3 | Terminated | CSL Behring | 134 | 2019-10-21 | 2025-12-09 |
| A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments Ustekinumab 6 mg/kg, Ustekinumab 90 mg, Placebo IV - Polymyositis, Dermatomyositis | Phase 3 | Terminated | Janssen Pharmaceutical K.K. | 51 | 2019-07-26 | 2025-04-29 |
| Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis Octanorm, Placebo - Dermatomyositis | Phase 3 | Terminated | Octapharma | 1 | 2018-08-02 | 2021-04-23 |
| A Clinical Trial for CTD-ILD Treatment N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease | Phase 2 / Phase 3 | Terminated | University of Michigan | 5 | 2011-12-01 | 2017-04-06 |
| Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis Prednisone, Methotrexate, Etanercept - Dermatomyositis | Phase 2 / Phase 3 | Terminated | Children's Hospital Medical Center, Cincinnati | 75 | 2002-08-01 | 2013-08-01 |
Dermatomyositis (6) · Arthritis, Rheumatoid (1) · Connective Tissue Diseases (1) · Lung Diseases, Interstitial (1) · Mixed Connective Tissue Disease (1) · Scleroderma, Diffuse (1) · Sjogren's Syndrome (1)
Muscular Diseases (6) · Musculoskeletal Diseases (6) · Myositis (6) · Nervous System Diseases (6) · Neuromuscular Diseases (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Connective Tissue Diseases (5) · Arthritis (1) · Autoimmune Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Immune System Diseases (1) · Joint Diseases (1)
Acetylcysteine (1) · Etanercept (1) · Hizentra (1) · Methotrexate (1) · Prednisone (1) · Ustekinumab (1) · gamma-Globulins (1) · ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1) · CSL Behring (1) · Children's Hospital Medical Center, Cincinnati (1) · Janssen Pharmaceutical K.K. (1) · Octapharma (1) · University of Michigan (1)
United States (4) · Japan (3) · France (2) · Germany (2) · Italy (2) · Poland (2) · Russia (2) · Spain (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Hungary (1) · Mexico (1) · South Korea (1)
2018 (1), 2023 (1), P60AR047784 (1)